| Date Filed | Type | Description |
| 10/04/2023 |
4
| Campbell Bradley L (President & CEO) has filed a Form 4 on AMICUS THERAPEUTICS, INC.|
Txns:
| Sold 11,200 shares
@ $11.2027, valued at
$125.5k
Sold 500 shares
@ $12.038, valued at
$6k
Exercised 11,700 options to buy
@ $2.94, valued at
$34.4k
|
|
| 10/02/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/03/2023 |
4
| Campbell Bradley L (President & CEO) has filed a Form 4 on AMICUS THERAPEUTICS, INC.|
Txns:
| Sold 20,000 shares
@ $13.3937, valued at
$267.9k
Exercised 11,700 options to buy
@ $2.94, valued at
$34.4k
|
|
| 08/01/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 07/14/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/12/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 07/06/2023 |
4
| Campbell Bradley L (President & CEO) has filed a Form 4 on AMICUS THERAPEUTICS, INC.|
Txns:
| Sold 11,700 shares
@ $12.3091, valued at
$144k
Exercised 11,700 options to buy
@ $2.94, valued at
$34.4k
|
|
| 07/03/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 06/08/2023 |
4
| Campbell Bradley L (President & CEO) has filed a Form 4 on AMICUS THERAPEUTICS, INC.|
Txns:
| Sold 8,300 shares
@ $12.5032, valued at
$103.8k
|
|
| 06/06/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 06/05/2023 |
4
| Campbell Bradley L (President & CEO) has filed a Form 4 on AMICUS THERAPEUTICS, INC.|
Txns:
| Sold 11,700 shares
@ $11.3626, valued at
$132.9k
Exercised 7,125 options to buy
@ $2.45, valued at
$17.5k
Exercised 4,575 options to buy
@ $2.94, valued at
$13.5k
|
|
| 06/01/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 05/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/01/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 04/05/2023 |
4
| Campbell Bradley L (President & CEO) has filed a Form 4 on AMICUS THERAPEUTICS, INC.|
Txns:
| Sold 11,700 shares
@ $11.2143, valued at
$131.2k
Exercised 11,700 options to buy
@ $2.45, valued at
$28.7k
|
|
| 03/17/2023 |
4
| Campbell Bradley L (President & CEO) has filed a Form 4 on AMICUS THERAPEUTICS, INC.|
Txns:
| Paid exercise price by delivering 13,375 shares
@ $11.43, valued at
$152.9k
|
|
| 02/03/2023 |
4
| Campbell Bradley L (President & CEO) has filed a Form 4 on AMICUS THERAPEUTICS, INC.|
Txns:
| Sold 20,000 shares
@ $12.9754, valued at
$259.5k
Exercised 11,700 options to buy
@ $2.45, valued at
$28.7k
|
|
| 01/13/2023 |
4
| Campbell Bradley L (President & CEO) has filed a Form 4 on AMICUS THERAPEUTICS, INC.|
Txns:
| Granted 98,040 shares
@ $0
Paid exercise price by delivering 50,147 shares
@ $12.02, valued at
$602.8k
|
|
| 01/11/2023 |
4
| Campbell Bradley L (President & CEO) has filed a Form 4 on AMICUS THERAPEUTICS, INC.|
Txns:
| Sold 11,700 shares
@ $11.432, valued at
$133.8k
Exercised 11,700 options to buy
@ $2.45, valued at
$28.7k
|
|
| 01/06/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/04/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/05/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/05/2022 |
4
| Campbell Bradley L (President & CEO) has filed a Form 4 on AMICUS THERAPEUTICS, INC.|
Txns:
| Sold 5,470 shares
@ $10.5346, valued at
$57.6k
Exercised 5,470 options to buy
@ $3.53, valued at
$19.3k
|
|
| 09/06/2022 |
4
| Campbell Bradley L (President & CEO) has filed a Form 4 on AMICUS THERAPEUTICS, INC.|
Txns:
| Sold 5,470 shares
@ $11.2914, valued at
$61.8k
Exercised 5,470 options to buy
@ $3.53, valued at
$19.3k
|
|
| 08/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/22/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/08/2022 |
4
| Campbell Bradley L (COO) has filed a Form 4 on AMICUS THERAPEUTICS, INC.|
Txns:
| Granted 104,603 shares
@ $0
Granted 187,970 options to buy
@ $8.95, valued at
$1.7M
|
|
| 03/22/2022 |
4
| Campbell Bradley L (COO) has filed a Form 4 on AMICUS THERAPEUTICS, INC.|
Txns:
| Sold 10,940 shares
@ $10.0024, valued at
$109.4k
Exercised 10,940 options to buy
@ $3.53, valued at
$38.6k
|
|
| 01/19/2022 |
4
| Campbell Bradley L (COO) has filed a Form 4 on AMICUS THERAPEUTICS, INC.|
Txns:
| Granted 63,317 shares
@ $0
Paid exercise price by delivering 32,386 shares
@ $10.53, valued at
$341k
|
|
| 01/04/2022 |
4
| Campbell Bradley L (COO) has filed a Form 4 on AMICUS THERAPEUTICS, INC.|
Txns:
| Paid exercise price by delivering 17,597 shares
@ $11.55, valued at
$203.2k
Paid exercise price by delivering 27,946 shares
@ $11.55, valued at
$322.8k
Paid exercise price by delivering 4,984 shares
@ $12.11, valued at
$60.4k
Sold 5,470 shares
@ $11.8611, valued at
$64.9k
Granted 154,711 shares
@ $0
Paid exercise price by delivering 7,368 shares
@ $12.48, valued at
$92k
Exercised 5,470 options to buy
@ $3.53, valued at
$19.3k
Granted 283,555 options to buy
@ $12.11, valued at
$3.4M
|
|
| 12/23/2021 |
4
| Campbell Bradley L (COO) has filed a Form 4 on AMICUS THERAPEUTICS, INC.|
Txns:
| Sold 3,000 shares
@ $11.6985, valued at
$35.1k
Exercised 3,000 options to buy
@ $4.38, valued at
$13.1k
|
|
| 12/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|